A series of announcements have been made today ahead of AIDS 2022, the 24th International AIDS Conference – including late-breaking study results, new WHO guidelines, a major voluntary licensing agreement and a new global coalition – built momentum for global access to long-acting cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention. Oral PrEP was […]
The US Food and Drugs Administration (FDA) has signed off on the first injectable PrEP treatment. Rather than needing to take a pill every day, people will now be able to protect themselves from HIV via a series of regular injections. The approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents for […]
As Sydney prepares to celebrate the 42nd Sydney Gay and Lesbian Mardi Gras this weekend, ACON – NSW’s leading HIV and sexuality and gender diverse health organisation – is encouraging revellers to look after themselves and their friends during the party season. ACON Deputy CEO Karen Price says that it is important that while people […]
For many LGBTIQ+ people, a simple routine trip to the GP can be an anxiety inducing experience. Each of us have our own unique set of circumstances that may require medical attention, and it can be incredibly difficult to find the right doctor or specialist that can offer the best treatment for the issue at […]
A controversial poster that argues that PrEP treatment is more effective than condom use has appeared around Perth. The ad promotes the uptake of PrEP but health professionals question how the ad downplays condom use. The advertising campaign from grassroots community group See It Clearly 2020 appeared on the streets of Melbourne earlier this month. […]
Rather than a once a day pill, in the future PrEP might be something you only have to think about once a year. Pre-exposure Prophylaxis (PrEP) treatments have seen the rate of new transmissions of HIV plummet in areas where the daily medication is readily available. Scientists are now testing more long-term ways of delivering […]
Pharmaceutical company Johnson and Johnson has announced the commencement of a widespread trial of an injectable vaccine for HIV. The vaccine will be tested on people across several countries in Europe as well as in the USA. The company is already running a trial in five countries in southern Africa. 3,800 men who have sex […]
The number of new diagnosis of HIV in Australia has hit an 18 year low, the success largely attributed to uptake of pre-exposure prophylaxis (PrEP) treatment. There’s still lots of work to be done though to reach the goal of no new transmissions by 2020, and rates amongst indigenous Australians and hetrosexual people are not […]
A research project covering relationships and HIV pre-exposure prophylaxis (PrEP) is seeking participants who are willing to take part in an upcoming round of interviews in Perth. The Re:PrEP Study is seeking men who use PrEP and who have primary partners (boyfriend, partner or husband) to take part an in interview about their relationships and […]
New research published in the health journal Sociology of Health & Illness has shown that some gay men consider PrEP to be a “social problem”. A series of focus groups held in New York showed some gay men consider people taking the HIV-preventative medication PrEP are lacking morals. The men described those on PrEP as immoral, irresponsible, naïve […]
